Author

M. Villalba

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Assay:flow cytometry· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. H. Laustsen· 1 shared D. Gitenay· 1 shared D. Tempe· 1 shared D.-N. Vo· 1 shared E. Rivera-de-Torre· 1 shared G. Bossis· 1 shared G. Cartron· 1 shared H. H. Eriksen· 1 shared

Activity by Year

2021-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. H. Laustsen

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

mRNA-delivered consensus allergens induce a neutralizing IgG response against food and pollen allergens

M. Moiniche, K. H. Johansen, J. Parron-Ballesteros, J. K. Corneliussen, H. H. Eriksen, J. V. Kringelum, S. R. Hadrup, O. Luengo, V. Cardona, J. Bartra, M. Pascal, J. Turnay, M. Villalba, R. Munter, T. P. Jenkins, , E. Rivera-de-Torre

This study shows that mRNA-delivered consensus allergens induce neutralizing IgG responses against multiple food and pollen allergens, offering a safer and broader allergy immunotherapy approach.

bioRxiv · Feb 26, 2024Bioengineering

The SUMOylation inhibitor TAK-981 (Subasumstat) triggers IFN-I-dependent activation of Natural Killer cells against Acute Myeloid Leukemias.

R. Hallal, M. De Toledo, D. Tempe, S. Zemiti, L. Coenon, D. Gitenay, S. George, S. Bonnet, L. Gabellier, G. Cartron, M. Pelegrin, M. Villalba, G. Bossis

This paper shows that TAK-981 activates NK cells against AML by inducing IFN-I secretion, enhancing their cytotoxicity and cytokine production.

bioRxiv · Feb 19, 2024 · PreprintCancer Biology

NK cells acquire CCR5 and CXCR4 by trogocytosis in people living with HIV-1

M. Villalba, D.-N. Vo, N. Leventoux, M. Campos-Mora, S. Gimenez, P. Corbeau

The paper shows NK cells acquire CCR5 and CXCR4 from T cells via trogocytosis in HIV patients, linking degranulation to this process and suggesting NK cells actively combat HIV-1.

bioRxiv · Dec 21, 2021Immunology